Cargando…
The Adenylate Cyclase Activator Forskolin Potentiates the Positive Inotropic Effect of the Phosphodiesterase Inhibitor Milrinone But Not of the Calcium Sensitizer Levosimendan nor of Its Hemodynamically Active Metabolites: An Apparent Conundrum
OR-1855 and OR-1896 are 2 hemodynamically active metabolites of the inodilator levosimendan, with calcium sensitizing activity, but their mechanism of action is still not fully understood. It has been previously reported that the positive inotropic effect of levosimendan is not potentiated by the ad...
Autores principales: | Levijoki, Jouko, Pollesello, Piero, Grossini, Elena, Papp, Zoltán |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Journal of Cardiovascular Pharmacology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9162272/ https://www.ncbi.nlm.nih.gov/pubmed/35170487 http://dx.doi.org/10.1097/FJC.0000000000001235 |
Ejemplares similares
-
Intermittent inotropic therapy with levosimendan vs. milrinone in advanced heart failure patients
por: Milwidsky, Assi, et al.
Publicado: (2022) -
Adenyl cyclase activator forskolin protects against Huntington's disease-like neurodegenerative disorders
por: Mehan, Sidharth, et al.
Publicado: (2017) -
Adenylate cyclase activator forskolin alleviates intracerebroventricular propionic acid-induced mitochondrial dysfunction of autistic rats
por: Mehan, Sidharth, et al.
Publicado: (2019) -
Levosimendan, milrinone, and dobutamine in experimental acute pulmonary embolism
por: Lyhne, Mads D., et al.
Publicado: (2021) -
Inotropic support in cardiogenic shock: who leads the battle, milrinone or dobutamine?
por: Lozada Martinez, Ivan David, et al.
Publicado: (2022)